OncoAlert Round Up for August 4th - 10th, 2023

Share :
Published: 14 Aug 2023
Views: 41
Dr Gil Morgan - Executive Director, OncoAlert

Dr Gil Morgan from OncoAlert gives his oncology highlights from social media for the week of August 4th - 10th, 2023.

He begins by highlighting the FDA approval of LONSURF (trifluridine/tipiracil) with bevacizumab for previously treated metastatic colorectal cancer following prior approval of single-agent LONSURF.

Dr Morgan also covers results from the KEYNOTE 671 trial of pembrolizumab or placebo plus platinum-based chemotherapy followed by resection and pembrolizumab or placebo for early-stage non-small cell lung cancer.

He concludes by inviting colleagues to the 'Multidisciplinary Perspectives in Breast Cancer' conference taking place on October 6th.

Follow Dr Morgan on twitter: @OncoAlert

Follow ecancer on twitter: @ecancer